Metastatic or Recurrent Gastric Adenocarcinoma
2 clinical trials · Condition
◉ Watch Metastatic or Recurrent Gastric Adenocarcinoma
| Record | Firm | Date |
|---|---|---|
| Envafolimab Combined With Chemotherapy in Metastatic or Recurrent Gastric Adenocarcinoma (NCT05237349) | Liangjun Zhu M.M. | 2022-03-01 |
| Trastuzumab in Combination With Capecitabine and Oxaliplatin(XELOX) in Patients With Advanced Gastric Cancer(AGC): Her+XELOX (NCT01396707) | Asan Medical Center | 2011-06-01 |
Track Metastatic or Recurrent Gastric Adenocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.